Cheekbone and Cheek Area Augmentation with the Briseida Technique: Analysis of 1,000 Cases and 8 Years of Experience
Journal of Surgery
Volume 3, Issue 1-1, February 2015, Pages: 8-10
Received: Nov. 26, 2014; Accepted: Dec. 1, 2014; Published: Dec. 31, 2014
Views 3213      Downloads 227
Natalia Ribé, Instut Dra. Natalia Ribé, Barcelona, Spain
Article Tools
Follow on us
Background. Non-surgical implant procedures have been used in facial rejuvenation, whether to improve the physical appearance or to correct asymmetries in the face. These procedures have quite a few advantages over surgical procedures, including an immediate cosmetic result and a short recovery period. Methods: The Briseida technique involves infiltrating a filler (Hyaluronic Acid) in a linear, retrograde and fan-shaped fashion at supraperiosteal or subcutaneous level. 1,000 patients between 25 and 75 years of age, treated during the past 10 years for cheekbone and/or cheek area augmentation with the Briseida technique, have been included in this revision. Results: shorter down-time, less product required, no serious adverse effects, longlasting results. Conclusions: The technique allows the oval of the face to be re-modelled. It is minimally invasive, quickly performed, and produces natural results with few and mild side effects.
Hyaluronic Acid, Filler, Cheekbone, Cheek, NASHA
To cite this article
Natalia Ribé, Cheekbone and Cheek Area Augmentation with the Briseida Technique: Analysis of 1,000 Cases and 8 Years of Experience, Journal of Surgery. Special Issue: Breakthroughs in Aesthetic Medicine. Vol. 3, No. 1-1, 2015, pp. 8-10. doi: 10.11648/j.js.s.2015030101.13
Verpaele A., Strand A. Restylane SubQ, a non-animal stabilized hyaluronic acid gel for soft tissue augmentation of the mid- and lower face. Aesth Plast Surg 2006;26(Suppl):10-7.
Wu W., Carlisle I., Huang P., Ribé N., Russo R., Schaar C., Verpaele A., Strand A. Novel administration technique for large-particle stabilized hyaluronic acid-based gel of nonanimal origin in facial tissue augmentation. Aesth Plast Surg 2010;34(1):88-95.
DeLorenzi C., Weinberg M., Solish N., Swift A. The long-term efficacy and safety of a subcutaneously injected large-particle stabilized hyaluronic acid-based gel of nonanimal origin in esthetic facial contouring. Dermatol Surg 2009;35(Suppl 1):313-21.
Bugge H, Negaard A, Skeie L, Bergersen B. Hyaluronic acid treatment of facial fat atrophy in HIV-positive patients. HIV Med 2007;8(8):475-82.
Malhotra R. Deep orbital Sub-Q restylane (nonanimal stabilized hyaluronic acid) for orbital volume enhancement in sighted and anophthalmic orbits. Arch Ophthalmol 2007 Dec;125(12):1623-9.
Lowe N.J., Grover R. Injectable hyaluronic acid implant for malar and mental enhancement. Dermatol Surg 2006; 32(7):881-5.
Skeie L., Bugge H., Negaard A., Bergersen BM.Skeie L., Bugge H., Negaard A. y Bergersen BM. Large particle hyaluronic acid for the treatment of facial lipoatrophy in HIV-positive patients: 3-year follow-up study. HIV Med 2010;11(3):170-7.
Naoum C. Cheek and facial contour augmentation with subcutaneous application of hyaluronic acid in HIV-positive patients. Kosmetische Medizin 2006;4:170-3.
Hinderer U. Profileplasty. Int Macro. J Aesthic. Plast. Surg 1971;Sep:1-12.
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
Tel: (001)347-983-5186